Cargando…

High neutrophil to lymphocyte ratio and decreased CD69(+)NK cells represent a phenotype of high risk in early-stage breast cancer patients

PURPOSE: Breast cancer (BC) is a highly heterogeneous disease presenting a broad range of clinical and molecular characteristics. In the past years, a growing body of evidence demonstrated that immune response plays a significant role in cancer outcome. However, immune prognostic markers are not com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandó, Pablo, Rizzo, Manglio, Roberti, María Paula, Juliá, Estefanía Paula, Pampena, María Betina, Pérez de la Puente, Constanza, Loza, Carlos Martín, Ponce, Carolina, Nadal, Jorge, Coló, Federico Andres, Mordoh, José, Levy, Estrella Mariel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961634/ https://www.ncbi.nlm.nih.gov/pubmed/29844687 http://dx.doi.org/10.2147/OTT.S160911

Ejemplares similares

Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
por: Juliá, Estefanía Paula, et al.
Publicado: (2018)

High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers
por: Mandó, Pablo, et al.
Publicado: (2017)

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15
por: Rocca, Yamila Sol, et al.
Publicado: (2016)

Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
por: Juliá, Estefanía Paula, et al.
Publicado: (2020)

Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
por: Levy, Estrella Mariel, et al.
Publicado: (2011)

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database
por: Fabiano, Verónica, et al.
Publicado: (2020)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

Natural Killer Cells as Helper Cells in Dendritic Cell Cancer Vaccines
por: Pampena, María Betina, et al.
Publicado: (2015)

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
por: Mandó, Pablo, et al.
Publicado: (2021)

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
por: Roberti, María Paula, et al.
Publicado: (2012)

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
por: Pampena, María B., et al.
Publicado: (2018)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Increased death and exhaustion of CD69(high) T cells and NK cells are associated with PD-1 antibody application in the in vitro co-culture system
por: Wang, Ying, et al.
Publicado: (2023)

Phenotypic Characterization of SLe(x)+ and CLA+ CD4+ T Cells
por: Kuri-Cervantes, Leticia, et al.
Publicado: (2020)

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy
por: Sanchez, María Belén, et al.
Publicado: (2023)

Aggressive NK-cell leukemia in a 69 years old Caucasian woman: a case report
por: Matzen, Sara Maj Hyldig, et al.
Publicado: (2015)

Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8(+) T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells
por: Barrio, María Marcela, et al.
Publicado: (2012)

69 Severe Cutaneus Drug Reactions: Description of a Serie Cases
por: Fernandes, Fátima, et al.
Publicado: (2012)

Dionysus in 69 /
Publicado: (1970)

Melanoma Vaccines and Modulation of the Immune System in the Clinical Setting: Building from New Realities
por: Madorsky-Rowdo, Florencia Paula, et al.
Publicado: (2012)

SPSC Meeting 69
por: Mannelli, M, et al.
Publicado: (2004)

Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
por: Barros, José Máximo, et al.
Publicado: (2021)

Radiation in the ps ring during , 69 and 70; limitations on future high-intensity running
por: Madsen, J.H.B
Publicado: (1971)

S69. CLINICAL HIGH RISK STATE: STRATIFICATION BASED ON CLINICAL PROFILE AND REDOX STATUS
por: Cleusix, Martine, et al.
Publicado: (2020)

High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer
por: Wang, Zhen, et al.
Publicado: (2023)

Transcriptomic landscape of the interaction between the entomopathogenic fungus Beauveria bassiana and its tolerant host Tribolium castaneum revealed by dual RNA-seq
por: Mannino, María Constanza, et al.
Publicado: (2023)

In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2017)

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
por: Jochems, Caroline, et al.
Publicado: (2016)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers
por: Bordoloi, Devivasha, et al.
Publicado: (2023)

Radiation in the PS ring during '69, '70 and '71; limitations on future high intensity running
por: Madsen, JHB
Publicado: (1972)

69th INTC Meeting
Publicado: (2022)

Erratum: Vol. 69, No. 42
Publicado: (2020)

Erratum: Vol. 69, No. 34
Publicado: (2020)

Erratum: Vol. 69, No. 29
Publicado: (2020)

Erratum: Vol. 69, No. 12
Publicado: (2020)

Erratum: Vol. 69, No. 32
Publicado: (2020)

Erratum: Vol. 69, No. 31
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_37lss0phqra9hh7sf3rka83rjr